All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank
CN
中文 English
Latest News

Latest News

Focusing on cutting-edge technologies and research advancements,
sharing Aniphe BioLab’s achievements in scientific innovation, Professional insights
and practical experience in the fields of laboratory animals and preclinical research.

Exhibition Review | Aniphe BioLab Exhibited at the National Academic Conference of the Cerebrovascular Function and Disease Branch of the Chinese Society for Neuroscience and the Tianyuan Forum on Brain Science Development

From May 10 to 12, the Cerebrovascular Function and Disease Branch of the Chinese Neuroscience Society, in collaboration with Nanjing Medical University, hosted… National Academic Conference of the Cerebrovascular Function and Disease Branch of the Chinese Society for Neuroscience, together with the Tianyuan Forum on Brain Science Development “It was successfully convened! This academic extravaganza brought together numerous experts and scholars, healthcare professionals, and leading figures from the biotechnology sector.”

The conference focused on international hot topics such as “Frontiers in Cerebrovascular Disease Research and Translational Science” and “Innovative Therapeutics and Regulatory Mechanisms for Brain Disorders,” fostering exchanges to explore the application of new technologies, methodologies, and theories in drug discovery for brain diseases.

 
Exhibition venue

At the event, Aniphe BioLab's staff warmly introduced the company’s products and technologies to every visitor, engaging in one‑on‑one, in‑depth discussions with clients and striving to deliver more professional, comprehensive solutions and technical services.

 

 

In addition, exquisite little gifts drew many attendees to stop and take a look, making the booth bustling with activity. Looking back on every moment of the exhibition, Aniphe BioLab would like to extend its heartfelt thanks to all our valued customers who graced us with their presence: Thank you for being with us every step of the way!

 

 
Aniphe BioLab

Jiangsu Aniphe BioLab Inc., established in 2018, is committed to becoming an internationally renowned preclinical pharmacodynamic evaluation company in the new era of biopharmaceutical development. Aniphe BioLab has built a comprehensive SPF‑grade laboratory animal facility that integrates animal breeding and husbandry, disease model development, and animal experimentation, covering areas such as oncology, neuroscience, and metabolism.

 

With over 5,000 mouse and rat cages at its disposal, and backed by a highly skilled technical team and an extensive animal resource base, Aniphe BioLab offers a wide array of disease‑specific animal models, including cerebral ischemia–reperfusion models in mice and rats (MACO/R), myocardial infarction and myocardial ischemia models (MI), transverse aortic constriction (TAC) models, patient‑derived xenograft (PDX) tumor models, cell‑line‑derived xenograft (CDX) tumor models, spinal cord injury (SCI) models, epilepsy models, Alzheimer’s disease (AD) models, and more. We also provide pharmacological and efficacy evaluation services tailored to these disease models. We warmly welcome inquiries from all interested clients!

 

 

PREVIOUS:

Disease Models | Humanized Mouse Models with Human PBMCs in Immunotherapy

NEXT:

Exhibition Invitation | From May 10 to 12 in Nanjing, Aniphe BioLab will be joining you at the National Academic Conference of the Cerebrovascular Function and Disease Branch of the Chinese Neuroscience Society